Robert J. Delaversano

Principal Financial Officer, U.S. GOLD CORP.

Companies

Grace Therapeutics, Inc.Vice President, Finance Jan 8, 2024 to now¹
ONCOSEC MEDICAL IncPrincipal Accounting Officer Feb 12, 2020 to Feb 9, 2023²
U.S. GOLD CORP.Principal Financial Officer Jan 17, 2018 to Apr 12, 2018³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

ONCOSEC MEDICAL Inc1,008 shares⁴Feb 9, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 9, 2023Sold 40 shares at $1.37 of ONCOSEC MEDICAL Inc⁴
Nov 4, 2022Sold 283 shares at $0.37 of ONCOSEC MEDICAL Inc⁵
Aug 5, 2022Sold 284 shares at $0.71 of ONCOSEC MEDICAL Inc⁶
May 6, 2022Sold 274 shares at $0.83 of ONCOSEC MEDICAL Inc⁷
Feb 9, 2022Sold 409 shares at $0.88 of ONCOSEC MEDICAL Inc⁸
Nov 1, 2021Sold 343 shares at $1.75 of ONCOSEC MEDICAL Inc⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARGrace Therapeutics, Inc., Vice President, Finance
2
SEC EDGARONCOSEC MEDICAL Inc, Principal Accounting Officer
3
SEC EDGARU.S. GOLD CORP., Principal Financial Officer
4
SEC EDGARONCOSEC MEDICAL Inc shares after the filing of Feb 9, 2023
5
SEC EDGARForm 4 filed Nov 4, 2022
6
SEC EDGARForm 4 filed Aug 5, 2022
7
SEC EDGARForm 4 filed May 6, 2022
8
SEC EDGARForm 4 filed Feb 11, 2022
9
SEC EDGARForm 4 filed Nov 3, 2021